SCHEMBL4899369

SCHEMBL4899369

Cc1n[nH]c2ccc(-c3nnc(NCCc4ccccc4)s3)cc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 7/20 0.50
CDK2 P24941 6/20 0.50
PIM1 P11309 3/20 0.48
PIM3 Q86V86 3/20 0.48
ROCK2 O75116 2/20 0.47
AURKB Q96GD4 2/20 0.47
KDM4E B2RXH2 3/20 0.44
GAA P10253 2/20 0.44
ALDH1A1 P00352 1/20 0.44
MMP3 P08254 1/20 0.44
APOBEC3G Q9HC16 1/20 0.44
PIM2 Q9P1W9 2/20 0.43
HTT P42858 2/20 0.42
MAPK1 P28482 2/20 0.42
MAPK3 P27361 1/20 0.42
LMNA P02545 1/20 0.42
MAPT P10636 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1601116 0.87 PIM1 (0.48) AKT1CDK2PIM1PIM3PIM2
SCHEMBL1601379 0.85 AKT1 (0.61) AKT1CDK2PIM1PIM3
SCHEMBL1601383 0.85 AKT1 (0.61) AKT1CDK2PIM1PIM3
SCHEMBL1602202 0.84 AKT1 (0.60) AKT1CDK2PIM1PIM3
SCHEMBL1602207 0.84 AKT1 (0.60) AKT1CDK2PIM1PIM3
SCHEMBL1602199 0.84 AKT1 (0.60) AKT1CDK2PIM1PIM3
Hydrochloric Acid SCHEMBL1600796 0.84 MMP3 (0.50) AKT1CDK2ROCK2ALDH1A1MMP3
SCHEMBL13438035 0.84 PIM1 (0.46) AKT1CDK2PIM1PIM3KDM4E
SCHEMBL3634511 0.83 AKT1 (0.59) AKT1CDK2PIM1PIM3
SCHEMBL1601674 0.83 AKT1 (0.74) AKT1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080242694-A1 Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith D SIDOCKY NEIL R 2008-10-02 US disclosed
US-20080242694-A1 Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith D SIDOCKY NEIL R 2008-10-02 US disclosed
US-20080242694-A1 Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith D SIDOCKY NEIL R 2008-10-02 US disclosed
WO-2008036308-A2 AMINO-SUBSTITUTED HETEROCYCLES, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH SIGNAL PHARMACEUTICALS, LLC (US) 2008-03-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080242694-A1 Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith JAK2, CHEK2, MTOR AKT1 26/4885CDK2 64/4885PIM1 914/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.